Status:

COMPLETED

Distal Radius Buckle Fracture Follow up Study

Lead Sponsor:

The Hospital for Sick Children

Collaborating Sponsors:

Physician Services Incorporated

Conditions:

Distal Radius Fracture

Eligibility:

All Genders

5-17 years

Phase:

NA

Brief Summary

The investigators will be enrolling children with distal radius buckle fractures, treating them with a removable splint and randomizing them to follow up as needed vs required follow up with a primary...

Detailed Description

Buckle fractures of the distal forearm that include the radius are the most common fracture in childhood, and the risk of this fracture occurring is about 1 in every 25 children.Despite the high frequ...

Eligibility Criteria

Inclusion

  • Otherwise healthy children aged 5 to 17 years who present to the study ED within three days of a wrist injury that is diagnosed in the ED as a distal radius buckle fracture will be eligible for enrolment. Furthermore, approximately 15% of children with this fracture have an associated ulnar buckle or ulnar styloid fracture. In previous similar research, children with these associated ulnar fractures were included in the study population. Thus, distal radius buckle fractures with or without an associated buckle/styloid fracture of the distal ulna will be eligible for participation.

Exclusion

  • Children at risk for pathologic fractures such as those with congenital or acquired bony disease (Appendix I).
  • Congenital anomalies of the extremities which may complicate clinical or radiographic assessment.
  • Multisystem trauma and multiple fractures of the same limb since these patients would require additional management and follow-up beyond that of an isolated buckle fracture.
  • Patients cognitively and developmentally delayed such that they are unable to communicate pain or have limited performance in activities of daily living at baseline.
  • Past history of ipsilateral distal radius/ulna fracture within 3 months of enrollment.
  • Patients who do not have phone or electronic mail access. This will preclude follow up of these patients.
  • Patients in whom the English language is so limited that consent and/or follow up is not possible.

Key Trial Info

Start Date :

April 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 30 2019

Estimated Enrollment :

149 Patients enrolled

Trial Details

Trial ID

NCT03248687

Start Date

April 1 2018

End Date

November 30 2019

Last Update

May 12 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kathy Boutis

Toronto, Ontario, Canada, M5G1X8